MOREY HAYMOND to Injections, Subcutaneous
This is a "connection" page, showing publications MOREY HAYMOND has written about Injections, Subcutaneous.
Connection Strength
0.458
-
Nonaqueous, Mini-Dose Glucagon for Treatment of Mild Hypoglycemia in Adults With Type 1 Diabetes: A Dose-Seeking Study. Diabetes Care. 2016 Mar; 39(3):465-8.
Score: 0.129
-
Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon. J Diabetes Sci Technol. 2015 Jan; 9(1):44-51.
Score: 0.116
-
Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemia. J Clin Endocrinol Metab. 2009 May; 94(5):1608-11.
Score: 0.079
-
Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes. Diabetes Care. 2001 Apr; 24(4):643-5.
Score: 0.046
-
rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery. Am J Physiol. 1997 Apr; 272(4 Pt 1):E628-33.
Score: 0.035
-
Position statement on jet injectors. Diabetes Care. 1988 Jul-Aug; 11(7):600-1.
Score: 0.019
-
The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes. Pediatr Res. 2007 Dec; 62(6):746-9.
Score: 0.018
-
Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med. 1984 Jun 28; 310(26):1706-11.
Score: 0.004
-
Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions. J Clin Invest. 1984 Jun; 73(6):1532-41.
Score: 0.004
-
Subcutaneous versus intraperitoneal administration of insulin on post-prandial hyperglycaemia and glucose turnover in alloxan diabetic dogs. Diabetologia. 1982 Jul; 23(1):61-4.
Score: 0.003
-
Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med. 1980 Dec 04; 303(23):1313-8.
Score: 0.003
-
Considerations for the programming of an open-loop insulin infusion device from the biostator glucose controller. Diabetes Care. 1980 Mar-Apr; 3(2):278-84.
Score: 0.003